Accelerant (ARX) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
14 May, 2026Executive summary
Exchange Written Premium grew 16% year-over-year to $1.14 billion, with 296 Members and 96 Risk Capital Partners as of March 31, 2026.
Adjusted EBITDA rose to $66 million, up 70% year-over-year, with a 24% margin; fee-based Adjusted EBITDA grew 112% year-over-year to $60 million.
Net revenue retention was 116%, reflecting strong growth from existing Members.
Third-party written premium increased to 41% of Exchange Written Premium, up from 19% in Q1 2025.
Adjusted net income was $38 million, up 118% year-over-year; GAAP net after-tax loss of $4 million due to share-based compensation.
Financial highlights
Q1 2026 revenue rose 54% year-over-year to $273 million; operating revenue up 57%.
Adjusted EBITDA reached $66 million, up from $39 million in Q1 2025.
Adjusted net income was $38 million; GAAP net after-tax loss of $4 million due to share-based compensation.
Consolidated GAAP EPS was a loss of $0.02; adjusted non-GAAP EPS was $0.17.
Net earned premiums more than doubled to $129.8 million, up 106% from Q1 2025.
Outlook and guidance
Q2 2026 guidance: exchange written premium $1.27–$1.32 billion, third-party premium $580–$620 million, adjusted EBITDA $60–$66 million.
Full-year 2026 guidance: exchange written premium at least $5.2 billion, third-party premium at least $2.3 billion, adjusted EBITDA at least $285 million.
Expect adjusted EBITDA margins for exchange services to be ~70% for the remainder of 2026.
Gross loss ratio expected to remain in the low-50s for 2026.
Premium placed with Accelerant Risk Exchange Insurers projected to increase, shifting revenue mix toward fee-based segments.
Latest events from Accelerant
- FY 2025 saw 35% premium growth, 149% EBITDA increase, and a $200M buyback plan.ARX
Q4 20253 May 2026 - Shareholders will vote on director elections and auditor ratification at the May 2026 meeting.ARX
Proxy filing30 Mar 2026 - Shareholders will vote on director elections and auditor ratification, with robust governance and oversight.ARX
Proxy filing30 Mar 2026 - Accelerant's IPO leverages a tech-driven insurance platform, targeting $355M in proceeds and rapid growth.ARX
Registration Filing29 Nov 2025 - Executive agreements set high base pay, strong severance, equity, and compliance terms.ARX
Registration Filing29 Nov 2025 - Tech-driven specialty insurance platform targets growth with IPO, but faces execution and regulatory risks.ARX
Registration Filing29 Nov 2025 - Q2 2025 delivered 42% premium growth, 29% EBITDA margin, and a return to profitability.ARX
Q2 202523 Nov 2025 - Adjusted EBITDA up 302% and Exchange Written Premium up 17% year-over-year.ARX
Q3 202514 Nov 2025 - Rapid growth, strong margins, and AI-driven efficiency define this specialty insurance platform.ARX
Investor Presentation11 Sep 2025